February 28, 2019

ICBI UPDATE  A Real-Time Science Report CLINICAL TRIALS IN ALZHEIMER’S AND PARKINSON’S DISEASES ARE FAILING: WHAT CAN BE DONE? With no drugs that can stop the progression...

December 28, 2018

PRO will ring in 2019 with optimism and the energy and spirit of New beginnings. We ring it in with great appreciation and homage...

December 28, 2018

A Real-Time Science Report LOOKING FORWARD TO 2019 Pharm Visit Preparation: ICB International, Inc., (“ICBII”), is excited to be visited by representatives of a European Pharmaceutical...

November 30, 2018

Common Link Between Parkinson’s, Alzheimer’s and Schizophrenia This article focuses on a potential common link related to the dysfunctional synaptic plasticity that science associates with...

November 30, 2018

September 27, 2018

A protein known as the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) is a member of the innate immune receptor of the TREM...

August 27, 2018

Approval of 5th Patent - ICB International, Inc., (“ICBII”), was notified on August 15, 2018, by the European Patent Office that Company’s 5th patent...

July 30, 2018

August already… where has the Summer gone? As we enjoy our HOT desert summer temperatures, we hope your “Lazy Days” are filled with time...

July 30, 2018

What is progressive supranuclear palsy? Progressive supranuclear palsy (PSP) is a rare brain disorder that affects movement, control of balance, speech, swallowing, vision, mood...

June 27, 2018

La Jolla, CA, June 25, 2018 – ICB International, Inc., (“ICBII”) announced today that the US Patent & Trademark Office (USPTO) approved two of...

June 27, 2018

April 30, 2018

Helplessness makes us susceptible to fall victims to the surroundings. This is exactly what happened to the numerous Parkinson’s disease patients who, due to...

March 31, 2018

March 30, 2018

ICBI UPDATE ON THE ROAD TO THE CURE PROMISING PRELIMINARY RESULTS FROM TREATMENT OF ALZHEIMER’S AND LEWY BODY PATIENTS WITH AN ANTIBODY DRUG Debilitation due to...

March 30, 2018

Could Parkinson’s Be Next? With the population living longer, neurodegenerative diseases such as Alzheimer’s (AD) and Parkinson’s (PD) diseases have become an increasing economic threat...